Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Orion Oyj    ORNBV   FI0009014377

ORION OYJ

(ORNBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Orion Oyj
Orion is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:

- generic, OTC and biosimilar drugs (46.3%);

- patented prescription products (38.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;

- animal products (8.2%);

- pharmaceutical ingredients (5.2%);

- other (1.7%): primarily outsourcing services.

Net sales are distributed geographically as follows: Finland (29.4%), Scandinavia (16.8%), Europe (31.8%), North America (9.8%) and other (12.2%).

Number of employees : 3 265 people.
Sales per Business
20182019Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals977.5099.9%1,051100.2% +7.52%
Sales per region
20182019Delta
EUR (in Million)%EUR (in Million)%
Rest of Europe304.1031.1%334.1031.8% +9.87%
Finland312.1031.9%308.9029.4% -1.03%
Scandinavia154.9015.8%176.7016.8% +14.07%
Other Countries148.0015.1%128.4012.2% -13.24%
North America58.306%103.009.8% +76.67%
Managers and Directors
NameAgeSinceTitle
Timo Antero Lappalainen582008President & Chief Executive Officer
Satu Maarit Ahomäki54-Senior Vice President-Commercial Operations
Jari Ilmari Karlson592010Chief Financial Officer & SVP-Animal Health
Sinikka Markkula-2011Chief Information Officer
Minna Ruotsalainen-2020Senior Vice President-Research & Development
Paula Rytilä-2017Chief Medical Officer & Vice President
Outi Vaarala, Dr.-2020Senior Vice President-Research & Development
Timo Tuomas Mikael Maasilta662016Vice Chairman
Erkki Mikael Silvennoinen642014Independent Director
Eija Ronkainen542016Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 106,011,485 100,762,622 95.0% 671,082 0.6% 86.5%
Stock B 20 35,122,793 21,342,528 60.8% 0 0.0%
Shareholders
NameEquities%
Lyxor International Asset Management SAS 3,017,813 2.85%
Norges Bank Investment Management 2,751,593 2.60%
The Vanguard Group, Inc. 2,729,408 2.57%
Amundi Asset Management SA (Investment Management) 2,057,507 1.94%
Handelsbanken Fonder AB 1,747,454 1.65%
The Social Insurance Institution of Finland (Invt Port) 1,658,368 1.56%
Keskinäinen Työeläkevakuutusyhtiö Varma 1,534,397 1.45%
Keskinäinen Työeläkevakuutusyhtiö Elo 1,533,855 1.45%
Keskinäinen Eläkevakuutusyhtiö Ilmarinen 1,512,629 1.43%
Dimensional Fund Advisors LP 1,316,006 1.24%
Holdings
NameEquities%Valuation
Orion Oyj (ORNBV) 671,0820.63%30,979,675 USD
Markets and indexes
-
- Main Market Large
- OMXH 25 / NASDAQ OMX Nordic 120, STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  ORNBV:FH
- Reuters Code :  ORNBV.HE
- Datastream Code :  
Company contact information
Orion Oyj
Orionintie 1A
PO Box 65
FI-02200 Espoo


Phone : +358 10 4261
Fax :
web site : http://www.orion.fi
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ORION OYJ0.00%6 597
JOHNSON & JOHNSON3.92%430 552
ROCHE HOLDING AG3.06%308 615
NOVARTIS AG2.73%220 726
MERCK & CO., INC.-1.00%204 882
PFIZER INC.-0.71%203 159
ABBVIE INC.3.46%195 720
ELI LILLY AND COMPANY22.09%186 883
NOVO NORDISK A/S4.18%168 128
AMGEN INC.10.26%147 580
BRISTOL-MYERS SQUIBB COMPANY4.08%145 890
ASTRAZENECA PLC6.19%139 483
SANOFI3.51%124 582
GLAXOSMITHKLINE PLC2.85%94 107
JIANGSU HENGRUI MEDICINE CO., LTD.1.02%92 231
CHUGAI PHARMACEUTICAL CO., LTD.2.11%88 992
DAIICHI SANKYO COMPANY, LIMITED1.27%66 704
BAYER AG8.73%62 617
TAKEDA PHARMACEUTICAL COMPANY LIMITED-4.47%54 029
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED20.88%34 701
ASTELLAS PHARMA INC.5.71%30 155
Connections : Orion Oyj